Infusion of autologous retrodifferentiated stem cells into patients with beta-thalassemia

TheScientificWorldJournal

Volumn 6, Issue , 2006, Pages 1278-1297

  Abuljadayel, Ilham Saleh ^a   Ahsan, Tasnim ^b   Quereshi, Huma ^c   Rizvi, Shakil ^d   Ahmed, Tamseela ^b   Khan, Sabiha Mirza ^e   Akhtar, Jawaid ^f   Dhoot, Ghazi ^a  

^a TriStem UK Limited   (United Kingdom)

^b JINNAH POSTGRADUATE MEDICAL CENTRE   (Pakistan)

^c Pakistan Medical Research Council   (Pakistan)

^d Kharadar General Hospital   (Pakistan)

^e National Medical Centre   (Pakistan)

^f Orthopedic and Medical Institute   (Pakistan)

Author keywords

Anaemia; Beta Thalassemia; Fetal Hemoglobin; Iron Overload; Retrodifferentiation; Serum Ferritin; Somatic Cell Reprogramming or Plasticity; Stem Cell Therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; CREATININE; FERRITIN; HEMOGLOBIN F; LACTATE DEHYDROGENASE;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOLOGOUS STEM CELL TRANSPLANTATION; BETA THALASSEMIA; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION; BONE AGE; BONE MARROW BIOPSY; CELL DIFFERENTIATION; CHELATION THERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ELECTROCARDIOGRAM; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN SYNTHESIS; HUMAN; KARYOTYPING; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE; LYMPHOCYTE FUNCTION; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; NEUTROPHIL COUNT; ONTOGENY; PLURIPOTENT STEM CELL; STEM CELL TRANSPLANTATION; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; ADULT STEM CELLS; BETA-THALASSEMIA; BLOOD TRANSFUSION; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIESIS; HEMOGLOBINS; HUMANS; MALE; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 33750834619     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2006.229     Document Type: Article

References (48)

1. Bank, A. (2005) Understanding globin regulation in β-thalassemia: it's as simple as α, β, γ, δ. J. Clin. Invest. 115, 1470-1473.
2. Weatherall, D.J. (2001) Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat. Rev. Genet. 2, 245-255.
3. Olivieri, N.F. and Brittenham, G.M. (1997) Iron-chelating therapy and the treatment of thalassemia. Blood 89, 739-761.
4. Olivieri, N.F. and Weatherall, D.J. (1998) The therapeutic reactivation of fetal haemoglobin. Hum. Mol. Genet. 7, 1655-1658.
5. Makis, A.C., Chaliasos, N., Hatzimichael, E.C., and Bourantas, K.L. (2001) Recombinant human erythropoietin therapy in a transfusion-dependent beta-thalassemia major patient. Ann. Hematol. 80, 492-495.
6. Reich, S., Buhrer, C., Henze, G., Ohlendorf, D., Mesche, M., Sinha, P., Kage, A., Muller, C., Vetter, B., and Kulozik, A.E. (2000) Oral isobutyramide reduces transfusion requirements in some patients with homozygous beta-thalassemia. Blood 96, 3357-3363.
7. Atweh, G.F. and Loukopoulos, D. (2001) Pharmacological induction of fetal hemoglobin in sickle cell disease and beta-thalassemia. Semin. Hematol. 38, 367-373.
8. Steinberg, M.H. (2002) Hydroxyurea treatment for sickle cell disease. TheScientificWorldJOURNAL 2, 1706-1728.
9. Fibach, E., Burke, L.P., Schechter, A.N., Noguchi, C.T., and Rodgers, G.P. (1993) Hydroxyurea increases fetal hemoglobin in cultured erythroid cells derived from normal individuals and patients with sickle cell anemia or beta-thalassemia. Blood 81, 1630-1635.
10. Fibach, E., Schechter, A.N., Noguchi, C.T., and Rodgers, G.P. (1994) Reducing erythropoietin in cultures of human erythroid precursors elevates the proportion of fetal haemoglobin. Br. J. Haematol. 88, 39-45.
11. Heller, P. and DeSimone, J. (1984) 5-Azacytidine and fetal hemoglobin. Am. J. Hematol. 17, 439-447.
12. McCaffrey, P.G., Newsome, D.A., Fibach, E., Yoshida, M., and Su, M.S. (1997) Induction of gamma-globin by histone deacetylase inhibitors. Blood 90, 2075-2083.
13. Quesenberry, P.J., Dooner, G., Colvin, G., and Abedi, M. (2005) Stem cell biology and the plasticity polemic. Exp. Hematol. 33, 389-394.
14. Abuljadayel, I.S. (2003) Induction of stem cell-like plasticity in mononuclear cells derived from unmobilised adult human peripheral blood. Curr. Med. Res. Opin. 19, 355-375.
15. Abuljadayel, I.S., Afghan, R.K., McCaffrey, T.A., et al. (2004) SCID repopulating cells derived from unmobilised adult human peripheral blood. Curr. Med. Res. Opin. 20; 87-100.
16. Abuljadayel, I.S. (2006) Harnessing pluripotency from differentiated cells: a regenerative source for tissue specific stem cell therapies. Curr. Stem Cell Res. Ther., 1; 325-331.
17. Miller, J.L. (2005) Signaled expression of fetal hemoglobin during development. Transfusion 45, 1229-1232.
18. Taketani, S. (2005) Aquisition, mobilization and utilization of cellular iron and heme: endless findings and growing evidence of tight regulation. Tohoku J. Exp. Med. 205, 297-318.
19. Weatherall, D.J. and Clegg, J.B. (1981) The distribution and incidence of beta thalassemia genes in different populations. In The Thalassemia Syndromes. 3rd ed. Blackwell Scientific, Oxford. pp. 295-309.
20. Weatherall, D.J. and Clegg, J.B. (2001) The Thalassemia Syndromes, 4th ed. Blackwell Science, Oxford.
21. Rund, D. and Rachmilewitz, E. (2005) Beta-thalassemia. N. Engl. J. Med. 353, 1135-1146.
22. Beutler, E., Hoffbrand, A.V., and Cook, J.D.(2003) Iron deficiency and overload. Haematology 1, 40-60.
23. Marinucci, M., Mavilio, F., Giuliani, A., Gabbianelli, M., Tentori, L., Jr., Tentori, L., Zorini, C.O., Lamberti, E., Palazzolo, A., and Lanzo, D. (1981) beta Thalassemia associated with increased HB F production. Evidence for the existence of a heterocellular hereditary persistence of fetal hemoglobin (HPFH) determinant linked to beta thalassemia in a southern Italian population. Hemoglobin 5, 1-17.
24. Hankins, J.S., Ware, R.E., Rogers, Z.R., Wynn, L.W., Lane, P.A., Scott, J.P., and Wang, W.C. (2005) Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study. Blood 106, 2269-2275.
25. Bradai, M., Abad, M.T., Pissard, S., Lamraoui, F., Skopinski, L., and de Montalembert, M. (2003) Hydroxyurea can eliminate transfusion requirements in children with severe beta-thalassemia. Blood 102, 1529-1530.
26. Verma, I.C. and Bijarnia, S. (2002) The burden of genetic disorders in India and a framework for community control. Community Genet. 5, 192-196.
27. La Nasa, G., Argiolu, F., Giardini, C., Pession, A., Fagioli, F., Caocci, G., Vacca, A., De Stefano, P., Piras, E., Ledda, A., Piroddi, A., Littera, R., Nesci, S., and Locatelli, F. (2005) Unrelated bone marrow transplantation for {beta}-thalassemia patients: the experience of the Italian Bone Marrow Transplant Group. Ann. N. Y. Acad. Sci. 1054, 186-195.
28. Abdulrazzaq, Y.M., Ibrahim, A., Al-Khayat, A.I., and Dawson, K. (2005) Beta-thalassemia major and its effect on amino acid metabolism and growth in patients in the United Arab Emirates. Clin. Chim. Acta 352, 183-190.
29. Walka, M.M., Sonntag, J., Kage, A., Dudenhausen, J.W., and Obladen, M. (1998) Complete blood counts from umbilical cords of healthy term newborns by two automated cytometers. Acta Haematol. 100, 167-173.
30. Lau, Y.L., Ma, E.S., Ha, S.Y., Chan, G.C., Chiu, D., Tang, M., Hawkins, B.R., Chan, V., and Liang, R.H. (1998) Sibling HLA-matched cord blood transplant for beta-thalassemia: report of two cases, expression of fetal hemoglobin, and review of the literature. J. Pediatr. Hematol. Oncol. 20, 477-481.
31. Fairbanks, V.F., Oliveros, R., Brandabur, J.H., Willis, R.R., and Fiester, R.F. (1980) Homozygous hemoglobin E mimics beta-thalassemia minor without anemia or hemolysis: hematologic, functional, and biosynthetic studies of first North American cases. Am. J. Hematol. 8, 109-121.
32. Waye, J.S., Chui, D.H., Eng, B., Cai, S.P., Coleman, M.B., Adams, J.G., 3rd, and Steinberg, M.H. (1991) Hb S/beta zero-thalassemia due to the approximately 1.4-kb deletion is associated with a relatively mild phenotype. Am. J. Hematol. 38, 108-112.
33. Dixit, A., Chatterjee, T.C., Mishra, P., Choudhry, D.R., Mahapatra, M., Tyagi, S., Kabra, M., Saxena, R., and Choudhry, V.P. (2005) Hydroxyurea in thalassemia intermedia - a promising therapy. Ann. Hematol. 84, 441-446.
34. Perrine, S.P., Castaneda, S.A., Boosalis, M.S., White, G.L., Jones, B.M., and Bohacek, R. (2005) Induction of fetal globin in {beta}-thalassemia: cellular obstacles and molecular progress. Ann. N. Y. Acad. Sci. 1054, 257-265.
35. El-Beshlawy, A., Seoud, H., Ibrahim, A., Youssry, I., Gabre, H., Isma'eel, H., Aoun, E., and Taher, A. (2005) Apoptosis in thalassemia major reduced by a butyrate derivative. Acta Haematol. 114, 155-159.
36. Davis, B.A. and Porter, J.B. (2000) Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia. Blood 95, 1229-1236.
37. Rombos, Y., Tzanetea, R., Konstantopoulos, K., Simitzis, S., Zervas, C., Kyriaki, P., Kavouklis, M., Aessopos, A., Sakellaropoulos, N., Karagiorga, M., Kalotychou, V., and Loukopoulos, D. (2000) Chelation therapy in patients with thalassemia using the orally active iron chelator deferiprone (L1). Haematologica 85, 115-117.
38. Kattamis, A. (2005) Combined therapy with deferoxamine and deferiprone. Ann. N. Y. Acad. Sci. 1054, 175-182.
39. Vaisman, B., Fibach, E., and Konijn, A.M. (1997) Utilization of intracellular ferritin iron for hemoglobin synthesis in developing human erythroid precursors. Blood 90, 831-838.
40. Thein, S.L. and Craig, J.E. (1998) Genetics of Hb F/F cell variance in adults and heterocellular hereditary persistence of fetal hemoglobin. Hemoglobin 22, 401-414.
41. Li, C.K., Chik, K.W., Lam, C.W., To, K.F., Yu, S.C., Lee, V., Shing, M.M., Cheung, A.Y., and Yuen, P.M. (2002) Liver disease in transfusion dependent thalassaemia major. Arch. Dis. Child. 86, 344-347.
42. Origa, R., Bina, P., Agus, A., Crobu, G., Defraia, E., Dessi, C., Leoni, G., Muroni, P.P., and Galanello, R. (2005) Combined therapy with deferiprone and desferrioxamine in thalassemia major. Haematologica 90, 1309-1314.
43. Larochelle, A., Vormoor, J., Lapidot, T., Sher, G., Furukawa, T., Li, Q., Shultz, L.D., Olivieri, N.F., Stamatoyannopoulos, G., and Dick, J.E. (1995) Engraftment of immune-deficient mice with primitive hematopoietic cells from beta-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols. Hum. Mol. Genet. 4, 163-172.
44. Borge, O.J., Ramsfjell, V., Cui, L., and Jacobsen, S.E. (1997) Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin. Blood 90, 2282-2292.
45. Ishikawa, F., Livingston, A.G., Minamiguchi, H., Wingard, J.R., and Ogawa, M. (2003) Human cord blood long-term engrafting cells are CD34+ CD38-. Leukemia 17, 960-964.
46. Lambotte, O., Cacoub, P., Costedoat, N., Le Moel, G., Amoura, Z., and Piette, J.C. (2003) High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation. J. Rheumatol. 30, 1027-1028.
47. Cappellini, M.D., Grespi, E., Cassinerio, E., Bignamini, D., and Fiorelli, G. (2005) Coagulation and splenectomy: an overview. Ann. N. Y. Acad. Sci. 1054, 317-324.
48. Hashmi, K.U., Khan, B., Ahmed, P., Hussain, I., Rasul, S., Hanif, E., Naeem, M., Iqbal, H., and Malik, H.S. (2004) Allogeneic bone marrow transplantation in beta-thalassaemia - single centre study. J. Pak. Med. Assoc. 54, 499-503.